These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 14752836

  • 1. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M.
    Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
    [Abstract] [Full Text] [Related]

  • 2. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, Fargion S.
    Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
    [Abstract] [Full Text] [Related]

  • 3. [The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease].
    Lee D, Jeong SH, Lee M, Cho YA, Kim JW, Park Y, Hwang JH, Kim NY, Lee DH.
    Korean J Hepatol; 2007 Jun; 13(2):174-84. PubMed ID: 17585191
    [Abstract] [Full Text] [Related]

  • 4. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S, Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J.
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance-associated hepatic iron overload.
    Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y.
    Gastroenterology; 1999 Nov; 117(5):1155-63. PubMed ID: 10535879
    [Abstract] [Full Text] [Related]

  • 6. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.
    Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G.
    Am J Gastroenterol; 2001 Aug; 96(8):2448-55. PubMed ID: 11513189
    [Abstract] [Full Text] [Related]

  • 7. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K, Stalke P, Romanowski T, Rzepko R, Bielawski KP.
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [Abstract] [Full Text] [Related]

  • 8. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P, Lonardo A, Carulli N.
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract] [Full Text] [Related]

  • 9. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.
    Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S.
    Dig Liver Dis; 2003 Mar; 35(3):172-8. PubMed ID: 12779071
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
    Raszeja-Wyszomirska J, Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J.
    World J Gastroenterol; 2010 May 28; 16(20):2531-6. PubMed ID: 20503453
    [Abstract] [Full Text] [Related]

  • 11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC, Barton JC, Acton RT, So J, Chan S, Adams PC.
    Clin Gastroenterol Hepatol; 2012 Apr 28; 10(4):412-6. PubMed ID: 22265917
    [Abstract] [Full Text] [Related]

  • 12. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
    Lin TJ, Lin CL, Wang CS, Liu SO, Liao LY.
    World J Gastroenterol; 2005 Jul 07; 11(25):3905-8. PubMed ID: 15991291
    [Abstract] [Full Text] [Related]

  • 14. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
    Tan TC, Crawford DH, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 07; 301(5):G865-76. PubMed ID: 21817060
    [Abstract] [Full Text] [Related]

  • 15. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.
    Nelson JE, Brunt EM, Kowdley KV, Nonalcoholic Steatohepatitis Clinical Research Network.
    Hepatology; 2012 Nov 07; 56(5):1730-40. PubMed ID: 22611049
    [Abstract] [Full Text] [Related]

  • 16. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR.
    Gastroenterology; 2005 Dec 07; 129(6):1937-43. PubMed ID: 16344062
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
    Zamin I, Mattos AA, Mattos AZ, Migon E, Bica C, Alexandre CO.
    Arq Gastroenterol; 2006 Dec 07; 43(3):224-8. PubMed ID: 17160239
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV.
    Gastroenterology; 2003 Feb 07; 124(2):318-26. PubMed ID: 12557137
    [Abstract] [Full Text] [Related]

  • 19. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL.
    Haematologica; 2007 Aug 07; 92(8):1037-42. PubMed ID: 17640859
    [Abstract] [Full Text] [Related]

  • 20. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.
    Hepatology; 2008 Sep 07; 48(3):792-8. PubMed ID: 18752331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.